Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear. METHODS: We used whole-exome sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with coronary heart disease using samples from four case-control studies that together enrolled 4726 participants with coronary heart disease and 3529 controls. To assess causality, we perturbed the function of Tet2, the second most commonly mutated gene linked to clonal hematopoiesis, in the hematopoietic cells of atherosclerosis-prone mice. RESULTS: In nested case-control analyses from two prospective cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7). In two retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, participants with CHIP had a risk of myocardial infarction that was 4.0 times as great as in noncarriers (95% CI, 2.4 to 6.7). Mutations in DNMT3A, TET2, ASXL1, and JAK2 were each individually associated with coronary heart disease. CHIP carriers with these mutations also had increased coronary-artery calcification, a marker of coronary atherosclerosis burden. Hypercholesterolemia-prone mice that were engrafted with bone marrow obtained from homozygous or heterozygous Tet2 knockout mice had larger atherosclerotic lesions in the aortic root and aorta than did mice that had received control bone marrow. Analyses of macrophages from Tet2 knockout mice showed elevated expression of several chemokine and cytokine genes that contribute to atherosclerosis. CONCLUSIONS: The presence of CHIP in peripheral-blood cells was associated with nearly a doubling in the risk of coronary heart disease in humans and with accelerated atherosclerosis in mice. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That subjects with clonal hematopoiesis are more susceptible to develop nonhematological, most notably cardiovascular, disease”
From Aging of hematopoietic stem cells (2018) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings are supported by recent findings demonstrating a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.83,84”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tet2 and Ppm1d mutant murine models have demonstrated an increased inflammatory signature in mutant macrophages, with heightened inflammatory cytokine production upon pro-inflammatory stimulation in vitro [31,32,69,70].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated IL-8 and IL-1β levels have been reported in patients with TET2 CH in the Pakistan Risk of Myocardial Infarction Study (PROMIS) [20,32]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
38 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Self-citationMacrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Self-citationAge-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Cited by
Items 101–200 of 1,015
Myeloid cell contributions to cardiovascular health and disease
Nahrendorf, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0064-0 · Cited by 258
Ma, J., Li, Y., Yang, X., Liu, K., Zhang, X., Zuo, X., Ye, R., Wang, Z., Shi, R., Meng, Q., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01430-7 · Cited by 243
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice
Wang, W., Liu, W., Fidler, T., Wang, Y., Tang, Y., Woods, B., Welch, C., Cai, B., Silvestre-Roig, C., Ai, D., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313283 · Cited by 262
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260
Clonal expansion in non-cancer tissues
Kakiuchi, N., & Ogawa, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00335-3 · Cited by 252
Pathogenesis of Atherosclerosis: A Multifactorial Process
Buja, L. M. (2023) · Ischemic Heart Disease · doi:10.1007/978-3-031-25879-4_2 · Cited by 248
Mas-Peiro, S., Hoffmann, J., Fichtlscherer, S., Dorsheimer, L., Rieger, M. A., Dimmeler, S., Vasa-Nicotera, M., & Zeiher, A. M. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz591 · Cited by 228
“Clonal haematopoiesis of indeterminate potential (CHIP), defined as the presence of an expanded somatic blood cell clone in subjects without other haematological abnormalities,(1) has recently shown to increase with age and is associated with coronary artery disease (CAD) and coronary calcification.(2,3) Mechanistical…”
BackgroundLibby (2019) · doi:10.1016/j.jacc.2019.06.007 · Cited by 247
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
Speer, T., Dimmeler, S., Schunk, S. J., Fliser, D., & Ridker, P. M. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00621-9 · Cited by 232
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
Ross, J. B., Myers, L. M., Noh, J. J., Collins, M. M., Carmody, A. B., Messer, R. J., Dhuey, E., Hasenkrug, K. J., & Weissman, I. L. (2024) · Nature · doi:10.1038/s41586-024-07238-x · Cited by 230
Circulating tumor DNA: current challenges for clinical utility
Dang, D. K., & Park, B. H. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154941 · Cited by 224
DNA methylation disruption reshapes the hematopoietic differentiation landscape
Izzo, F., Lee, S. C., Poran, A., Chaligne, R., Gaiti, F., Gross, B., Murali, R. R., Deochand, S. D., Ang, C., Jones, P. W., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0595-4 · Cited by 236
Association of clonal hematopoiesis with chronic obstructive pulmonary disease
Miller, P. G., Qiao, D., Rojas-Quintero, J., Honigberg, M. C., Sperling, A. S., Gibson, C. J., Bick, A. G., Niroula, A., McConkey, M. E., Sandoval, B., et al. (2022) · Blood · doi:10.1182/blood.2021013531 · Cited by 235
Self-citationAdelman, E. R., Huang, H.-T., Roisman, A., Olsson, A., Colaprico, A., Qin, T., Lindsley, R. C., Bejar, R., Salomonis, N., Grimes, H. L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1474 · Cited by 221
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Duncavage, E. J., Bagg, A., Hasserjian, R. P., DiNardo, C. D., Godley, L. A., Iacobucci, I., Jaiswal, S., Malcovati, L., Vannucchi, A. M., Patel, K. P., et al. (2022) · Blood · doi:10.1182/blood.2022015853 · Cited by 217
Self-citationAn inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis
Abegunde, S. O., Buckstein, R., Wells, R. A., & Rauh, M. J. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2017.11.002 · Cited by 230
Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis
Tyrrell, D. J., Blin, M. G., Song, J., Wood, S. C., Zhang, M., Beard, D. A., & Goldstein, D. R. (2020) · Circulation Research · doi:10.1161/circresaha.119.315644 · Cited by 224
Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement
Mensah, G. A., Arnold, N., Prabhu, S. D., Ridker, P. M., & Welty, F. K. (2025) · JACC · doi:10.1016/j.jacc.2025.08.047 · Cited by 177
Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Xu, Y.-P., Lv, L., Liu, Y., Smith, M. D., Li, W.-C., Tan, X.-M., Cheng, M., Li, Z., Bovino, M., Aubé, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129317 · Cited by 228
Pascual-Figal, D. A., Bayes-Genis, A., Díez-Díez, M., Hernández-Vicente, Á., Vázquez-Andrés, D., de la Barrera, J., Vazquez, E., Quintas, A., Zuriaga, M. A., Asensio-López, M. C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.028 · Cited by 221
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Zaman, S., Wasfy, J. H., Kapil, V., Ziaeian, B., Parsonage, W. A., Sriswasdi, S., Chico, T. J. A., Capodanno, D., Colleran, R., Sutton, N. R., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00055-8 · Cited by 203
Chronic immune response dysregulation in MDS pathogenesis
Barreyro, L., Chlon, T. M., & Starczynowski, D. T. (2018) · Blood · doi:10.1182/blood-2018-03-784116 · Cited by 226
Clonal haematopoiesis and risk of chronic liver disease
Wong, W. J., Emdin, C., Bick, A. G., Zekavat, S. M., Niroula, A., Pirruccello, J. P., Dichtel, L., Griffin, G., Uddin, M. M., Gibson, C. J., et al. (2023) · Nature · doi:10.1038/s41586-023-05857-4 · Cited by 220
Self-citationAssociation of Clonal Hematopoiesis With Incident Heart Failure
Yu, B., Roberts, M. B., Raffield, L. M., Zekavat, S. M., Nguyen, N. Q. H., Biggs, M. L., Brown, M. R., Griffin, G., Desai, P., Correa, A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.085 · Cited by 231
Self-citationCampia, U., Moslehi, J. J., Amiri-Kordestani, L., Barac, A., Beckman, J. A., Chism, D. D., Cohen, P., Groarke, J. D., Herrmann, J., Reilly, C. M., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000641 · Cited by 217
Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation
Frick, M., Chan, W., Arends, C. M., Hablesreiter, R., Halik, A., Heuser, M., Michonneau, D., Blau, O., Hoyer, K., Christen, F., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2184 · Cited by 223
Vascular toxic effects of cancer therapies
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0347-2 · Cited by 206
Zhang, L., Dong, X., Lee, M., Maslov, A. Y., Wang, T., & Vijg, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902510116 · Cited by 222
“This is in keeping with the discovery of a decreased number of lymphoid hematopoietic lineages during ageing11 and may underlie the CHIP phenomenon found in a fraction of elderly40.”
BackgroundMethodInfluentialAging and the rise of somatic cancer-associated mutations in normal tissues
Risques, R. A., & Kennedy, S. R. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007108 · Cited by 216
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke
Bhattacharya, R., Zekavat, S. M., Haessler, J., Fornage, M., Raffield, L., Uddin, M. M., Bick, A. G., Niroula, A., Yu, B., Gibson, C., et al. (2022) · Stroke · doi:10.1161/strokeaha.121.037388 · Cited by 222
Self-citationPrevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Cordua, S., Kjaer, L., Skov, V., Pallisgaard, N., Hasselbalch, H. C., & Ellervik, C. (2019) · Blood · doi:10.1182/blood.2019001113 · Cited by 212
Gladyshev, V. N., Kritchevsky, S. B., Clarke, S. G., Cuervo, A. M., Fiehn, O., de Magalhães, J. P., Mau, T., Maes, M., Moritz, R. L., Niedernhofer, L. J., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00150-3 · Cited by 198
Grayson, P. C., Patel, B. A., & Young, N. S. (2021) · Blood · doi:10.1182/blood.2021011455 · Cited by 256
Monogenic and polygenic inheritance become instruments for clonal selection
Loh, P.-R., Genovese, G., & McCarroll, S. A. (2020) · Nature · doi:10.1038/s41586-020-2430-6 · Cited by 228
“4b and Supplementary Table 17)—suggesting that the relationship between clonal hematopoiesis and cardiovascular disease [5, 29] arises from clones that harbor specific mutations.”
BackgroundInfluentialMetabolic Alterations in Aging Macrophages: Ingredients for Inflammaging?
van Beek, A. A., Van den Bossche, J., Mastroberardino, P. G., de Winther, M. P. J., & Leenen, P. J. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.007 · Cited by 207
Understanding intrinsic hematopoietic stem cell aging
Mejia-Ramirez, E., & Florian, M. C. (2020) · Haematologica · doi:10.3324/haematol.2018.211342 · Cited by 186
Van Egeren, D., Escabi, J., Nguyen, M., Liu, S., Reilly, C. R., Patel, S., Kamaz, B., Kalyva, M., DeAngelo, D. J., Galinsky, I., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.02.001 · Cited by 206
“Notably, JAK2-V617F clonal hematopoiesis is associated with an increased risk of cardiovascular disease (Jaiswal et al., 2017) and venous thrombosis (Cordua et al.”
BackgroundCell-free DNA analysis in current cancer clinical trials: a review
Cisneros-Villanueva, M., Hidalgo-Pérez, L., Rios-Romero, M., Cedro-Tanda, A., Ruiz-Villavicencio, C. A., Page, K., Hastings, R., Fernandez-Garcia, D., Allsopp, R., Fonseca-Montaño, M. A., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01696-0 · Cited by 198
“Its presence has also been associated with the risk for haematological neoplasms, cardiovascular diseases and overall mortality [83], and its prevalence has also been found elevated in patients with solid tumours [84].”
BackgroundFuster, J. J., Zuriaga, M. A., Zorita, V., MacLauchlan, S., Polackal, M. N., Viana-Huete, V., Ferrer-Pérez, A., Matesanz, N., Herrero-Cervera, A., Sano, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108326 · Cited by 204
NLRP3 inflammasome pathways in atherosclerosis
Baldrighi, M., Mallat, Z., & Li, X. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.027 · Cited by 202
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Dhindsa, D. S., Sandesara, P. B., Shapiro, M. D., & Wong, N. D. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00088 · Cited by 192
“Recently, clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a risk factor for ASCVD through inflammatory pathways (21).”
BackgroundCOVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
Smadja, D. M., Mentzer, S. J., Fontenay, M., Laffan, M. A., Ackermann, M., Helms, J., Jonigk, D., Chocron, R., Pier, G. B., Gendron, N., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09805-6 · Cited by 200
Libby, P., & Kobold, S. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz058 · Cited by 197
Self-citationZanoli, L., Briet, M., Empana, J. P., Cunha, P. G., Mäki-Petäjä, K. M., Protogerou, A. D., Tedgui, A., Touyz, R. M., Schiffrin, E. L., Spronck, B., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002508 · Cited by 191
“The inflammatory response in arteries is triggered by humoral, physical and mechanical factors including vasoactive hormones [angiotensin II (AII), endothelin-1, aldosterone], mechanical factors (vascular stretch, pressure), ischaemic insults (ischaemia-reperfusion, hypoxia), metabolic factors (hyperglycaemia, oxidize…”
BackgroundHematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection
Zekavat, S. M., Lin, S.-H., Bick, A. G., Liu, A., Paruchuri, K., Wang, C., Uddin, M. M., Ye, Y., Yu, Z., Liu, X., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01371-0 · Cited by 198
Self-citationA Revised Perspective of Skeletal Stem Cell Biology
Ambrosi, T. H., Longaker, M. T., & Chan, C. K. F. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00189 · Cited by 196
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Arends, C. M., Galan-Sousa, J., Hoyer, K., Chan, W., Jäger, M., Yoshida, K., Seemann, R., Noerenberg, D., Waldhueter, N., Fleischer-Notter, H., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0047-7 · Cited by 194
“Moreover, individuals with clonal mutations have an elevated risk of atherosclerotic cardiovascular disease and death from coronary heart disease [15].”
BackgroundMethodClinical consequences of clonal hematopoiesis of indeterminate potential
Steensma, D. P. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020222 · Cited by 190
“The latter seems likely in view of clinical cardiovascular risk with other mutations (albeit lower with DNMT3A).(9)”
BackgroundRare variant associations with plasma protein levels in the UK Biobank
Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2023) · Nature · doi:10.1038/s41586-023-06547-x · Cited by 193
“In our revised article, we now quantify the number of genes with trans-CDS signals that are targets of currently approved drugs in DrugBank (n=2,627 genes).”
BackgroundNLRP3 inflammasome as a key driver of vascular disease
Takahashi, M. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab010 · Cited by 188
Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis
Avagyan, S., Henninger, J. E., Mannherz, W. P., Mistry, M., Yoon, J., Yang, S., Weber, M. C., Moore, J. L., & Zon, L. I. (2021) · Science · doi:10.1126/science.aba9304 · Cited by 192
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Chan, H. T., Chin, Y. M., Nakamura, Y., & Low, S.-K. (2020) · Cancers · doi:10.3390/cancers12082277 · Cited by 183
“Particularly, in individuals bearing JAK2-V617F, the relative risk of coronary heart disease was 12 times higher compared to non-carriers, which was also much higher compared to mutations in other genes [55].”
BackgroundResultCardiovascular Risk Factors Are Associated With Future Cancer
Lau, E. S., Paniagua, S. M., Liu, E., Jovani, M., Li, S. X., Takvorian, K., Suthahar, N., Cheng, S., Splansky, G. L., Januzzi, J. L., et al. (2021) · JACC: CardioOncology · doi:10.1016/j.jaccao.2020.12.003 · Cited by 185
“Clonal hematopoiesis of indeterminate potential, an expansion of somatic blood cell clones associated with increased risk of hematological cancers, was recently implicated in CVD development, as demonstrated by a near doubling of coronary heart disease risk among clonal hematopoiesis of indeterminate potential carrier…”
BackgroundClinical consequences of clonal hematopoiesis of indeterminate potential
Steensma, D. P. (2018) · Hematology · doi:10.1182/asheducation-2018.1.264 · Cited by 188
“The latter seems likely in view of clinical cardiovascular risk with other mutations (albeit lower with DNMT3A).(9)”
BackgroundInnate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
Trowbridge, J. J., & Starczynowski, D. T. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201544 · Cited by 189
de Boer, R. A., Hulot, J.-S., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J., Bertero, E., Coats, A. J. S., Čelutkienė, J., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2029 · Cited by 183
The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation
Schilperoort, M., Ngai, D., Sukka, S. R., Avrampou, K., Shi, H., & Tabas, I. (2023) · Immunological Reviews · doi:10.1111/imr.13214 · Cited by 170
“44 The essential amino acid tryptophan fuels the synthesis of ky-nurenine, serotonin, and indoles.”
BackgroundLinking Heart Failure to Cancer: Background Evidence and Research Perspectives
Bertero, E., Canepa, M., Maack, C., & Ameri, P. (2018) · Circulation · doi:10.1161/circulationaha.118.033603 · Cited by 178
Genetic basis and molecular profiling in myeloproliferative neoplasms
Luque Paz, D., Kralovics, R., & Skoda, R. C. (2023) · Blood · doi:10.1182/blood.2022017578 · Cited by 166
Clonal hematopoiesis and non-hematologic disorders
Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182
Self-citationPredictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Loftfield, E., Zhou, W., Graubard, B. I., Yeager, M., Chanock, S. J., Freedman, N. D., & Machiela, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-30759-1 · Cited by 178
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
Ridker, P. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.082 · Cited by 174
“Finally, recent evidence suggests that clonal hematopoiesis, a normal effect of aging in which certain white blood cell lines mutationally come to dominate others, is also associated with increased cardiovascular risk (80,81).”
BackgroundClonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking
Dawoud, A. A. Z., Tapper, W. J., & Cross, N. C. P. (2020) · Leukemia · doi:10.1038/s41375-020-0896-8 · Cited by 181
Baldini, C., Moriconi, F. R., Galimberti, S., Libby, P., & De Caterina, R. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab447 · Cited by 167
Self-citationAmpomah, P. B., Cai, B., Sukka, S. R., Gerlach, B. D., Yurdagul, A., Wang, X., Kuriakose, G., Darville, L. N. F., Sun, Y., Sidoli, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00551-7 · Cited by 173
“Thus, a topic for future study will be to determine if the degree of DNMT3A lowering in CHIP is enough to compromise the DNMT3A-PGE 2 -TGF β 1 pathway in atherosclerotic lesional macrophages, thus providing at least one mechanism linking DNMT3A CHIP to CAD.”
InfluentialTargeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Xu, S., Kamato, D., Little, P. J., Nakagawa, S., Pelisek, J., & Jin, Z. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.003 · Cited by 173
Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
Aboumsallem, J. P., Moslehi, J., & de Boer, R. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013754 · Cited by 173
“The absence of the CHiP driver gene TET2 in mice resulted in accelerated atherosclerosis progression and higher predisposition to cardiac dysfunction.(81,82) Experiments in murine models reported an elevated IL-1b activity in the presence of CHiP mutations.”
BackgroundVlasschaert, C., Mack, T., Heimlich, J. B., Niroula, A., Uddin, M. M., Weinstock, J. S., Sharber, B., Silver, A. J., Xu, Y., Savona, M. R., et al. (2023) · Blood · doi:10.1182/blood.2022018825 · Cited by 160
Self-citationInflammation as a Therapeutic Target in Atherosclerosis
Nguyen, M., Fernando, S., Schwarz, N., Tan, J., Bursill, C., & Psaltis, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081109 · Cited by 168
“Atherosclerosis-prone mice transplanted with TET2-deficient haematopoietic stem cells developed larger atherosclerotic lesions than controls without significant differences in lipid levels [117].”
BackgroundEmerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation
Schultze, J. L., Mass, E., & Schlitzer, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.019 · Cited by 167
The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis
Head, T., Daunert, S., & Goldschmidt-Clermont, P. J. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00216 · Cited by 166
“Moreover, this study demonstrated that the loss of function mutation of Tet2 (the second most commonly mutated gene in CHIP) led to accelerated atherosclerosis in mice, likely as a result of transcriptional modifications of associated macrophages (Jaiswal et al., 2017).”
BackgroundMouhieddine, T. H., Sperling, A. S., Redd, R., Park, J., Leventhal, M., Gibson, C. J., Manier, S., Nassar, A. H., Capelletti, M., Huynh, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16805-5 · Cited by 167
Self-citationGumuser, E. D., Schuermans, A., Cho, S. M. J., Sporn, Z. A., Uddin, M. M., Paruchuri, K., Nakao, T., Yu, Z., Haidermota, S., Hornsby, W., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.401 · Cited by 165
Self-citationJAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Sano, S., Wang, Y., Yura, Y., Sano, M., Oshima, K., Yang, Y., Katanasaka, Y., Min, K.-D., Matsuura, S., Ravid, K., et al. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.013 · Cited by 170
“This JAK2 -mediated clonal hematopoiesis has been associated with an increased incidence of cardiovascular disease (13).”
BackgroundResultInfluentialProgression of Early Subclinical Atherosclerosis (PESA) Study
Ibanez, B., Fernández-Ortiz, A., Fernández-Friera, L., García-Lunar, I., Andrés, V., & Fuster, V. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.011 · Cited by 159
Self-citationClonal hematopoiesis is associated with protection from Alzheimer’s disease
Bouzid, H., Belk, J. A., Jan, M., Qi, Y., Sarnowski, C., Wirth, S., Ma, L., Chrostek, M. R., Ahmad, H., Nachun, D., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02397-2 · Cited by 169
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer (4, 15) and cardiovascular outcomes (6, 7).”
InfluentialSelf-citationCauses and consequences of clonal hematopoiesis
Weeks, L. D., & Ebert, B. L. (2023) · Blood · doi:10.1182/blood.2023022222 · Cited by 169
Self-citationCardiovascular Disease, Aging, and Clonal Hematopoiesis
Evans, M. A., Sano, S., & Walsh, K. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032544 · Cited by 161
“Therefore, a follow-up investigation was conducted to directly test the hypothesis that CHIP is associated with an increase in the incidence of cardiovascular disease (14).”
BackgroundMethodResultInfluentialDonor Clonal Hematopoiesis and Recipient Outcomes After Transplantation
Gibson, C. J., Kim, H. T., Zhao, L., Murdock, H. M., Hambley, B., Ogata, A., Madero-Marroquin, R., Wang, S., Green, L., Fleharty, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02286 · Cited by 168
Self-citationEvaluating measurable residual disease in acute myeloid leukemia
Ravandi, F., Walter, R. B., & Freeman, S. D. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016378 · Cited by 162
Assmus, B., Cremer, S., Kirschbaum, K., Culmann, D., Kiefer, K., Dorsheimer, L., Rasper, T., Abou-El-Ardat, K., Herrmann, E., Berkowitsch, A., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa845 · Cited by 160
Wang, Y., Sano, S., Yura, Y., Ke, Z., Sano, M., Oshima, K., Ogawa, H., Horitani, K., Min, K.-D., Miura-Yura, E., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135204 · Cited by 167
“In this regard, studies have associated clonal hematopoiesis with increased risks of coronary heart disease, stroke, and early-onset myocardial infarction (7, 13).”
BackgroundAdvances in understanding of angioimmunoblastic T-cell lymphoma
Chiba, S., & Sakata-Yanagimoto, M. (2020) · Leukemia · doi:10.1038/s41375-020-0990-y · Cited by 161
Somatic Mutations in “Benign” Disease
Mustjoki, S., & Young, N. S. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2101920 · Cited by 166
TET2-mutant clonal hematopoiesis and risk of gout
Agrawal, M., Niroula, A., Cunin, P., McConkey, M., Shkolnik, V., Kim, P. G., Wong, W. J., Weeks, L. D., Lin, A. E., Miller, P. G., et al. (2022) · Blood · doi:10.1182/blood.2022015384 · Cited by 160
Self-citationDnmt3a -mutated clonal hematopoiesis promotes osteoporosis
Kim, P. G., Niroula, A., Shkolnik, V., McConkey, M., Lin, A. E., Słabicki, M., Kemp, J. P., Bick, A., Gibson, C. J., Griffin, G., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20211872 · Cited by 164
“Studies of the effect of hematopoietic-specific Tet2 inactivation on cardiovascular disease have demonstrated that atherosclerosis-susceptible Ldlr−/− mice fed a high-fat diet (HFD) increases inflammatory cytokine levels released from Tet2deficient macrophages (Fuster et al., 2017; Jaiswal et al., 2017).”
InfluentialSelf-citationFuster, J. J., & Walsh, K. (2018) · Circulation Research · doi:10.1161/circresaha.117.312115 · Cited by 162
“cification was 12-fold in individuals exhibiting a variant allele fraction >10%.(47)”
BackgroundResultInfluentialAtherosclerosis Is an Epigenetic Disease
Xu, S., Pelisek, J., & Jin, Z. G. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.04.007 · Cited by 161
“More recently, two landmark studies from the Walsh laboratory [10] and the Ebert laboratory [11], have independently demonstrated the important role of hematopoietic DNA demethylating enzyme TET2 in preventing atherosclerosis, which does so by repressing the upregulation of pro-inflammatory cytokines and chemokines as…”
BackgroundUnraveling Hematopoiesis through the Lens of Genomics
Liggett, L. A., & Sankaran, V. G. (2020) · Cell · doi:10.1016/j.cell.2020.08.030 · Cited by 163
Monocyte-endothelial cell interactions in vascular and tissue remodeling
Medrano-Bosch, M., Simón-Codina, B., Jiménez, W., Edelman, E. R., & Melgar-Lesmes, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196033 · Cited by 150
Clonal haematopoiesis and dysregulation of the immune system
Belizaire, R., Wong, W. J., Robinette, M. L., & Ebert, B. L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00843-3 · Cited by 161
“…haematopoietic cells exacerbate the development of atherosclerosis in Ldlr −/− mice 97,129 ; interestingly, this effect was observed in the context of myeloid-specific Tet2 deficiency, implying that the presence of a mutation in myeloid cells was sufficient to promote atherosclerosis 97,129 .”
InfluentialSelf-citationTargeting the Immune System in Atherosclerosis
Zhao, T. X., & Mallat, Z. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.083 · Cited by 158
Atherosclerosis Is a Smooth Muscle Cell–Driven Tumor-Like Disease
Pan, H., Ho, S. E., Xue, C., Cui, J. G., Johanson, Q., Sachs, N., Ross, L. S., Li, F., Solomon, R. A., Connolly, E. S., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067587 · Cited by 165
“8 The phenomenon of SMC clonal expansion in human atherosclerosis was also discovered several decades ago 9 and has recently been corroborated through studies applying multicolor SMC lineage labeling in mouse models.”
BackgroundResultTP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
Zekavat, S. M., Viana-Huete, V., Matesanz, N., Jorshery, S. D., Zuriaga, M. A., Uddin, M. M., Trinder, M., Paruchuri, K., Zorita, V., Ferrer-Pérez, A., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00206-6 · Cited by 146
“In previous work, Jaiswal et al.4 demonstrated an increased risk of CAD among individuals with CHIP through DNMT3A, TET2, ASXL1 and JAK2 somatic driver mutations.”
BackgroundInfluentialSelf-citationLibby, P. (2021) · Cells · doi:10.3390/cells10040951 · Cited by 167
Self-citationRisk of Cancer After Diagnosis of Cardiovascular Disease
Bell, C., Lei, X. J., Haas, A. M., Baylis, R. A., Gao, H., Luo, L., Giordano, S. H., Wehner, M. R., Nead, K. T., & Leeper, N. J. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.01.010 · Cited by 167
“While the precise molecular mechanism linking CHIP mutations to heart disease remains undefined, inflammasome activation is thought to be central to this process (46-49).”
BackgroundNeutrophils in Physiology and Pathology
Aroca-Crevillén, A., Vicanolo, T., Ovadia, S., & Hidalgo, A. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-015009 · Cited by 170
Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
Jin, Y., & Fu, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012219 · Cited by 148
“This finding demonstrated that the recruitment of small number of Tet2mutant cells in the plaque may be adequate to fuel atherosclerosis by promoting NLRP3/pro-interleukin-1bdriven vascular inflammation.84 It is reasonable to speculate that individuals carrying somatic mutations in Tet2 may respond much more favorably…”
BackgroundInfluentialComorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
Cook, E. K., Izukawa, T., Young, S., Rosen, G., Jamali, M., Zhang, L., Johnson, D., Bain, E., Hilland, J., Ferrone, C. K., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018024729 · Cited by 145
“CH is associated with some diseases of aging; groups have described increased risk of subsequent hematological cancer,(3,4) atherosclerotic cardiovascular disease and stroke,(3,4) and all-cause mortality.(3,6) Self-reported asthma and chronic obstructive pulmonary disease were also associated with TET2-based CH,(7) an…”
BackgroundNeutrophils in aging and aging‐related pathologies
Avondt, K. V., Strecker, J., Tulotta, C., Minnerup, J., Schulz, C., & Soehnlein, O. (2022) · Immunological Reviews · doi:10.1111/imr.13153 · Cited by 165
Metadata
- Authors
- Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., Baber, U., Mehran, R., Fuster, V., Danesh, J., Frossard, P., Saleheen, D., Melander, O., Sukhova, G. K., Neuberg, D., Libby, P., Kathiresan, S., & Ebert, B. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- ORCID
- Jaiswal, Siddhartha
- Natarajan, Pradeep
- Silver, Alexander J.
- Gibson, Christopher J.
- Bick, Alexander G.
- McConkey, Marie
- Gupta, Namrata
- Gabriel, Stacey
- Ardissino, Diego
- Baber, Usman
- Mehran, Roxana
- Danesh, John
- Saleheen, Danish
- Melander, Olle
- Sukhova, Galina K.
- Neuberg, Donna
- Libby, Peter
- Kathiresan, Sekar
- Ebert, Benjamin L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-07-13
- Volume
- 377
- Issue
- 2
- Pages
- 111-121
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6717509
- OpenAlex
- W2628145035
- Cited by
- 2,683
- References
- 37
- Citations by year
- 2026: 303 · 2025: 322 · 2024: 347 · 2023: 338 · 2022: 371 · 2021: 303 · 2020: 263 · 2019: 215 · 2018: 169 · 2017: 44
- FWCI
- 143.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/014/24067)
- Novo Nordisk Fonden (NNF14OC0009819, NNF13OC0005339)
- Medical Research Council (MR/L003120/1)
- National Heart, Lung, and Blood Institute (R01HL082945, R01HL080472, RC2HL101834, T32HL116324)
- National Human Genome Research Institute (U54HG003067)
- Fogarty International Center (RC1TW008485)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- clonal hematopoiesis of indeterminate potential, atherosclerotic cardiovascular disease, coronary artery disease, myocardial infarction, coronary artery calcification, TET2 mutation, DNMT3A, ASXL1, JAK2, somatic mutations, atherosclerosis, cytokines and chemokines, macrophages, bone marrow transplantation
- MeSH terms
- Animals, Coronary Disease, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mutation, Risk, Case-Control Studies, Sequence Analysis, DNA, Mice, Knockout, Genetic Predisposition to Disease, Atherosclerosis, Mice, Exome, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.